Urgent Advocacy Needed: Extend 75/25 Blended Rate Relief

Published in Government Relations on February 22, 2024

As Senate and House leaders are continuing their efforts to secure funding beyond March 2024, the importance of the 75/25 blended-rate provision is becoming increasingly apparent. Under the current Continuing Resolution, the DMEPOS rates dropped on average 30% Jan. 1, 2024. There is a lot of work being done actively to get it included in an upcoming spending package, but we need your help!

We NEED every leader within our industry to personally contact healthcare staffers for your Senators and Representatives about S. 1294 and H.R. 5555. When you do, please request that they reach out in their respective leaders to support the inclusion of DMEPOS relief in non-rural areas within the next funding legislative package.

TAKE ACTION S. 1294               TAKE ACTION H.R. 5555

Extending the 75/25 blended rate not only benefits non-CBA, non-rural suppliers, but it also has broader implications:

  • Medicaid Rates: States that use Medicare rates as a guideline will benefit.
  • TRICARE and Private Payers: These rates influence other payers as well.

Furthermore, advocating for this relief reinforces the message to CMS that a long-term, market-based solution for Medicare ratemaking in the HME sector is crucial.

Even if you have already reached out to your legislator, we ask that you do so again! For an easy way to reach out to your legislator, please visit our action center.

Ike Isaacson's Update on the 75/25 Blended Rate

If you would like to learn more about this bill, please click here. While the key committees continue to work through bill priorities, we need your congressperson to stand up for you and for your clients to ensure that our bills are passed and that services can continue.

Let’s be Champions of Change to make sure that congressional leaders understand the urgency of this issue. Together, we can secure the relief our industry needs.

From Our Experts

HR1 Passes House, Advances to President Trump's Desk for Signature thumbnail HR1 Passes House, Advances to President Trump's Desk for Signature After extensive negotiations and partisan debate, the House has officially passed HR1, clearing the path for the bill to be signed into law by President Donald Trump. The legislation, which aims to reduce federal healthcare expenditures, contains several provisions that may impact the durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) industry. CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program thumbnail CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program On June 30, 2025, CMS filed the anticipated Proposed Rule that includes updates to the Competitive Bidding Program (CBP). Public comments are due 60 days from June 30, 2025. Below is a high-level summary of the rule. It is critical to note that, according to the Proposed Rule Fact Sheet dated June 30, 2025, CMS has stated that they have not announced the specific product categories they are bidding or the specific timeframe for the next competition. Those specifics will be forthcoming in a fu Senate Narrowly Passes HR1, Sending It Back to House for Final Approval thumbnail Senate Narrowly Passes HR1, Sending It Back to House for Final Approval President Donald Trump's sweeping legislative package, formally titled the One Big, Beautiful Bill Act, now referred to as HR1., cleared the Senate today in a dramatic 51–50 vote, with Vice President JD Vance casting the tie-breaking vote. The bill now returns to the House, where lawmakers must decide whether to adopt the Senate's revised version or negotiate further changes before it can reach the president's desk. Several Prominent Medicaid Provisions in Senate's Budget Bill Deemed in Violation of Byrd Rule thumbnail Several Prominent Medicaid Provisions in Senate's Budget Bill Deemed in Violation of Byrd Rule Senate Parliamentarian Elizabeth MacDonough advised this week that multiple Medicaid provisions in the Senate's reconciliation bill would violate Senate procedure by violating the Byrd Rule. The Byrd Rule is a Senate-specific procedural process that allows Senators to prevent or block inclusion of extraneous provisions in reconciliation bills. Other provisions are still under review. Evaluating the Value of a Payer Contract thumbnail Evaluating the Value of a Payer Contract In our last article, Key Payers Denied Your Application Citing Their Network Is Closed – Now What?, we discussed strategies for addressing payer contracting denials due to a closed network. As indicated, this process can be an extremely time-consuming exercise with no guarantees and mixed results. Below are a few things to consider as you evaluate whether a contract is worth the extra effort. Webinar: Webinar: "Navigating The New CMS Landscape: RADs, HMVs, and Supplier Survival" on June 25 at 1 p.m. CT. The Centers for Medicare & Medicaid Services (CMS) has released its final National Coverage Determination (NCD) for RADs and HMVs used in treating chronic respiratory failure due to COPD. While the rule potentially expands access to bilevel ST therapy (RADs), it also introduces complex compliance requirements, tighter usage criteria, and increased documentation burdens—without additional reimbursement. The Return of Competitive Bidding thumbnail The Return of Competitive Bidding The Centers for Medicare & Medicaid Services (CMS) appear to be laying the groundwork for another round of the Competitive Bidding Program (CBP). While full implementation will take a couple of years, an official announcement is expected this summer—potentially as early as July. Out With The Old RAC, In With The New thumbnail Out With The Old RAC, In With The New On April 28, 2025, CMS awarded Cotiviti GOV Services LLC, the new RAC Recovery Audit Contractor (RAC) Region 3, 4, and 5 contracts. RAC Region 3 includes the following Medicare Administrative Contractor (MAC) jurisdictions: JJ, JM, and JN. RAC Region 4 includes jurisdictions: JE, JF, and JL. And RAC Region 5 includes jurisdictions: JA, JB, JC, JD, as well as the HH/H MACs: J6, J15, JK, and JM.